— All Articles —
The latest from The Peptide Brief.
Fake Retatrutide: £2m of Pens Seized as MHRA Steps Up UK Raids
Retatrutide is not approved in the UK, but fake pens carrying its name are turning up in large numbers. What…
Petrelintide ZUPREME-1 Results: What the Full Data Shows
A new once-weekly weight-loss injection works differently from Wegovy and Mounjaro. Its full Phase 2 results have now been published,…
Retatrutide TRIUMPH-2 Results: What the Full Type 2 Diabetes Data Actually Shows
The full TRIUMPH-2 paper adds responder rates, a more cautious 18.8% analysis, blood sugar and blood pressure results and new…
New Ozempic vs Mounjaro Heart Study: What the 6% Difference Really Means
New real-world data presented at EASD suggests a small difference in major cardiovascular events between people who increased their Ozempic…
CagriSema vs Mounjaro: What the New Phase 3 Trial Really Shows
Novo Nordisk says CagriSema produced more weight loss than tirzepatide in the Phase 3 REIMAGINE 5 trial. We explain what…
What Is EloraTZP? Lilly’s Eloralintide and Tirzepatide Combination Shows 17% Weight Loss in Early Trial
EloraTZP is an investigational combination product that pairs tirzepatide — the active ingredient in Mounjaro — with a separate compound…
Retatrutide vs Mounjaro: What the Latest Trial Data Really Shows — and What It Doesn’t
New trial results suggest retatrutide may produce greater average weight loss than tirzepatide, but the comparison is more complicated than…
Eloralintide: What Is It and Why Are People Comparing It to Cagrilintide?
A new name is starting to appear in weight loss medication communities across the UK. People who have recently discovered…
Alluvi Healthcare Retatrutide Investigation: £200,000 Frozen in UK Weight-Loss Jab Probe
The MHRA has obtained court orders freezing more than £200,000 linked to Alluvi Healthcare as part of an ongoing investigation…